Skip to main content
. 2019 Mar 14;19(5):3685–3695. doi: 10.3892/mmr.2019.10033

Figure 2.

Figure 2.

Detection of Tif1γ plasma levels by ELISA. Tif1γ was quantified in plasma samples from patients with breast cancer (n=110) and healthy controls (n=110). The average concentration was 22.90 ng/ml in control participants, and 13.89 ng/ml in patients with breast cancer. P=0.0008. Tif1γ, transcription intermediary factor 1 γ.